Broad Institute

MAY 9, 2024

Genomic Interpretation, seqr and Matchmaker Exchange By Rose Circeo May 9, 2024 Breadcrumb Home Genomic Interpretation, seqr and Matchmaker Exchange The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

APRIL 25, 2024

Structural Variation in Human Genomes By Rose Circeo April 25, 2024 Breadcrumb Home Structural Variation in Human Genomes The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

APRIL 11, 2024

Understand Single Cell ATAC-Seq Data Analysis By Rose Circeo April 11, 2024 Breadcrumb Home Understand Single Cell ATAC-Seq Data Analysis The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Agency IQ

MAY 31, 2024

Start Date End Date Event Event Type Organization 6/03/2024 6/03/2024 Product Management Service (PMS) Product UI and API training (access & navigation) Webinar/Seminar ( OPEN ) EMA 6/03/2024 6/07/2024 Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the E.U.:

Regulations 40

Regulations Production Compliance Pharmaceuticals 40

Agency IQ

MARCH 1, 2024

Start Date End Date Event Event Type Organization 2/28/2024 2/28/2024 Workshop on Medical Radioisotopes Conference ( CLOSED ) Belgian Council Presidency 2/28/2024 2/28/2024 The path to diagnosis – the challenge of rare diseases Webinar/ Seminar ( OPEN ) Martin Zeitz Center for Rare Diseases at the University Hospital Hamburg-Eppendorf 2/28/2024 (..)

Regulations 40

Regulations Biosimilars Clinical Trials Production 40

Broad Institute

MARCH 22, 2024

Rare Variant Interpretation By Rose Circeo March 22, 2024 Breadcrumb Home Rare Variant Interpretation The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease. Videos are also available for streaming at the Broad's publicly available YouTube channel.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

APRIL 4, 2024

A Practical guide to bulk RNA-seq, including guidelines for eQTL analysis By Rose Circeo April 4, 2024 Breadcrumb Home A Practical guide to bulk RNA-seq, including guidelines for eQTL analysis The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

RNA 52

RNA Bioethics Disease Research 52

Agency IQ

OCTOBER 27, 2023

Upcoming Webinar Hosted by Xtalks Webinar/Seminar ( OPEN) Xtalks 11/6/2023 11/6/2023 What is the evidence for high-risk medical devices in the field of cardiovascular disease and diabetes?

Regulations 40

Regulations Pharmaceuticals Production Packaging 40

Broad Institute

FEBRUARY 15, 2024

Ethical considerations in genomics research By Rose Circeo February 15, 2024 Breadcrumb Home Ethical considerations in genomics research The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Research Disease 52

Broad Institute

FEBRUARY 8, 2024

Integration of GWAS and functional data By Rose Circeo February 8, 2024 Breadcrumb Home Integration of GWAS and functional data The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

FEBRUARY 1, 2024

A brief history of non-invasive prenatal testing By Rose Circeo February 1, 2024 Breadcrumb Home A brief history of non-invasive prenatal testing The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

JANUARY 18, 2024

MPG Primer: All of Us Primer, Part 2 By Rose Circeo January 18, 2024 Breadcrumb Home MPG Primer: All of Us Primer, Part 2 The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

JANUARY 11, 2024

MPG Primer: All of Us Primer, Part 1 By Rose Circeo January 11, 2024 Breadcrumb Home MPG Primer: All of Us Primer, Part 1 The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

DECEMBER 7, 2023

MPG Primer: Basics of gene editing/CRISPR By Rose Circeo December 7, 2023 Breadcrumb Home MPG Primer: Basics of gene editing/CRISPR The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

OCTOBER 19, 2023

MPG Primer: Introduction to fine-mapping By Rose Circeo October 19, 2023 Breadcrumb Home MPG Primer: Introduction to fine-mapping The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

NOVEMBER 30, 2023

If you'd like more information about the primer or have suggestions for future topics, please contact seminar series organizers Sarah Morton and Nicole Rockweiler. Videos are also available for streaming at the Broad's publicly available YouTube channel.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

OCTOBER 12, 2023

MPG Primer: Modeling rare variation and calculating genetic constraint By Rose Circeo October 12, 2023 Breadcrumb Home MPG Primer: Modeling rare variation and calculating genetic constraint The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

SEPTEMBER 28, 2023

Mono- and bi-valent allele impact By Rose Circeo September 28, 2023 Breadcrumb Home Mono- and bi-valent allele impact The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

JUNE 21, 2023

Harmonization of deeply sequenced genomes By admin June 21, 2023 Breadcrumb Home Harmonization of deeply sequenced genomes The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Broad Institute

JUNE 1, 2023

Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencing By Rose Circeo June 1, 2023 Breadcrumb Home Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencing The Primer on Medical and Population Genetics is a series of weekly lectures on genetics topics related to human populations and disease.

Bioethics 52

Bioethics Disease Research 52

Agency IQ

AUGUST 2, 2024

For example, on July 25, the Hungarian presidency hosted an informal meeting of health ministers to discuss health issues, such as mitigating the effect of cardiovascular diseases and implementing the European Health Data Space (EHDS).

Regulations 40

Regulations Clinical Trials Production International 40

Drug Discovery World

OCTOBER 18, 2023

Adeno-associated virus (AAV) vector-based gene therapies hold exceptional promise across a range of disease areas. Such therapies have become an appealing drug modality for multiple conditions, including monogenic disorders, cancers, and infectious diseases. Accessed 26 Jul 23. Available at [link] 2: U.S. Accessed 26 Jul 23.

Therapies 163

Therapies Clinical Trials FDA Approval Virus 163

KIF1A

MAY 4, 2024

Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. By talking to groups with these mutations, we may identify other diseases whose patients have KIF1A variants. She once worked at SACELLS Biotechnology Co.

Science 116

Science Medical Schools RNA Research 116

The Pharma Data

OCTOBER 14, 2020

Each year, more than 700 000 people die from vector-borne diseases (VBDs) such as malaria, dengue, schistosomiasis, leishmaniasis, Chagas disease, yellow fever and Japanese encephalitis, among others. Taken together, these diseases exact an immense toll on economies and can impede both rural and urban development. New guidance.

Government 52

Government Disease Research 52

The Pharma Data

DECEMBER 22, 2020

23, 2020 /PRNewswire/ — Hansa Biopharma , the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company’s management team will present at the 39th Annual J.P. SEB Healthcare Seminar on Monday January 18, 2021 , with a presentation at 10:10 am CET on the same day.

Science 40

Science Therapies Disease 40

Drug Discovery World

OCTOBER 13, 2022

There were 127 exhibitors, 180 posters, 40 technology speakers, 52 scientific speakers as well as a series of eight seminars focused on automation and technology which DDW organised and moderated in the dedicated Tech Theatre. . Over the two days at ExCel, 1554 delegates attended the event. Of those delegates, 75% work in drug discovery.

Drugs 130

Drugs Cell Based Assays Science Assay Development 130

KIF1A

MARCH 9, 2024

Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. During her undergraduate studies, she worked on heart disease research in Chi Kueng Lam’s laboratory at the University of Delaware. Meet our Guest Bloggers!

Laboratories 111

Laboratories Science Research Disease 111

Agency IQ

JULY 8, 2024

For delegated acts, the co-legislators usually have two months to object to the proposals but cannot amend them. For implementing acts, the Commission is required to consult with a committee before adoption.

Regulations 40

Regulations Pharmaceuticals Production Compliance 40

Drug Target Review

MAY 31, 2024

I currently lead a talented team of multi-disciplinary scientists who are dedicated to discovering a treatment for Parkinson’s Disease, a debilitating condition with significant unmet medical need. She is an active voice for diversity and inclusion in the Sciences.

Organic Chemistry 45

Organic Chemistry Computational Chemistry Small Molecule Disease 45

Agency IQ

MAY 3, 2024

Start Date End Date Event Event Type Organization 4/30/2024 4/30/2024 Seminar No. Start Date End Date Event Event Type Organization 4/30/2024 4/30/2024 Seminar No. Start Date End Date Event Event Type Organization 4/30/2024 4/30/2024 Seminar No. Start Date End Date Event Event Type Organization 4/30/2024 4/30/2024 Seminar No.

Regulations 40

Regulations Clinical Trials Production Biosimilars 40

The Pharma Data

JANUARY 6, 2021

In two exploratory cohorts, up to 100 patients with moderate Chronic Kidney Disease (CKD) and up to 100 patients with COVID-19 will be enrolled. AM-Pharma’s purpose is to save and improve the lives of patients confronted with kidney disease, sepsis and organ injury. Seminars in Nephrology, 2015; 35(1): 2-11. 5 Alobaidi, R.

Trials 52

Trials Hospitals Treatment International 52

Practical Cheminformatics

DECEMBER 7, 2023

In these cases, broadening your skillset into other areas like medicinal chemistry, pharmacology, biophysics, pharmacokinetics, and disease biology is important. The Medicinal Chemistry Gordon Research Seminar ( GRS ) provides a condensed version of ResMed. There are many ways to broaden your skills. Ask a lot of questions.

Computational Chemistry 90

Computational Chemistry Pharmacokinetics Pharmaceutical Companies Drugs 90

Agency IQ

AUGUST 23, 2024

Introducing Lias for a plenary at the event, Gutierrez said: “Courtney is in the paperwork for the seminar, she’s put down as the Acting Director. This project, which is focused first on CDx (which are largely Class III products) and IVDs for infectious diseases, was also seen as a key aspect of implementing the LDT rule.

FDA 40

FDA Laboratories Regulations Clinical Trials 40

Agency IQ

OCTOBER 6, 2023

Taking a closer look, nearly half of the products were reviewed by the Office of Oncologic Diseases. The largest portion of reviews after that were 14% (3 NMEs) each with the Office of Neuroscience and the Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine.

FDA 52

FDA Biosimilars Science Production 52

Drug Discovery World

AUGUST 16, 2022

Numerous underlying factors, ranging from genetics, environment, lifestyle, co-morbidities, income level, ethnicity, and beyond, converge to influence an individual’s risk for cancer and how the disease is managed. Additionally, when planning department seminars, invite speakers from underrepresented communities.

Research 130

Research Clinical Trials Trials Drug Development 130

Agency IQ

DECEMBER 1, 2023

12/29/2023 FDORA, Section 3202 Orphan Drug Program : FDA will convene a public meeting (or several) to solicit input from stakeholders regarding rare disease patient burdens, treatment options, side effects of treatments, etc. and Annex 1 Conference Joel Welch December 12 AgencyIQ Looking ahead to 2024: Regulatory Forecast for the U.S.

FDA 40

FDA Science Regulations Production 40